173 related articles for article (PubMed ID: 38179948)
21. Mycobacterium tuberculosis Arylamine N-Acetyltransferase Acetylates and Thus Inactivates para-Aminosalicylic Acid.
Wang X; Yang S; Gu J; Deng J
Antimicrob Agents Chemother; 2016 Dec; 60(12):7505-7508. PubMed ID: 27671064
[TBL] [Abstract][Full Text] [Related]
22. Frequency and patterns of first- and second-line drug resistance-conferring mutations in Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients in a cross-sectional study in Tigray Region, Ethiopia.
Welekidan LN; Skjerve E; Dejene TA; Gebremichael MW; Brynildsrud O; Tønjum T; Yimer SA
J Glob Antimicrob Resist; 2021 Mar; 24():6-13. PubMed ID: 33279682
[TBL] [Abstract][Full Text] [Related]
23. Assessing capreomycin resistance on tlyA deficient and point mutation (G695A) Mycobacterium tuberculosis strains using multi-omics analysis.
Zhao J; Wei W; Yan H; Zhou Y; Li Z; Chen Y; Zhang C; Zeng J; Chen T; Zhou L
Int J Med Microbiol; 2019 Nov; 309(7):151323. PubMed ID: 31279617
[TBL] [Abstract][Full Text] [Related]
24. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
[TBL] [Abstract][Full Text] [Related]
25. [Study on the prevalence of Beijing genotype Mycobacterium tuberculosis and its relationship with second-line anti-tuberculosis drug resistance].
Liang C; Zhang XX; Xing Q; Yi JL; Zhang YQ; Li CY; Liu Y; Tang SJ
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):356-361. PubMed ID: 32294818
[No Abstract] [Full Text] [Related]
26. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study.
Mboowa G; Namaganda C; Ssengooba W
BMC Infect Dis; 2014 Sep; 14():481. PubMed ID: 25190040
[TBL] [Abstract][Full Text] [Related]
27. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
[TBL] [Abstract][Full Text] [Related]
28. Genetic Diversity and Drug Susceptibility of Mycobacterium tuberculosis Isolates in a Remote Mountain Area of China.
Ma AJ; Wang SF; Fan JL; Zhao B; He GX; Zhao YL
Biomed Environ Sci; 2018 May; 31(5):351-362. PubMed ID: 29866217
[TBL] [Abstract][Full Text] [Related]
29. Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012.
Zhang X; Liu L; Zhang Y; Dai G; Huang H; Jin Q
Antimicrob Agents Chemother; 2015 Feb; 59(2):1320-4. PubMed ID: 25421465
[TBL] [Abstract][Full Text] [Related]
30. First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness.
De Maio F; Cingolani A; Bianco DM; Salustri A; Palucci I; Sanguinetti M; Delogu G; Sali M
Int J Med Microbiol; 2021 May; 311(4):151506. PubMed ID: 33906074
[TBL] [Abstract][Full Text] [Related]
31. para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
Zheng J; Rubin EJ; Bifani P; Mathys V; Lim V; Au M; Jang J; Nam J; Dick T; Walker JR; Pethe K; Camacho LR
J Biol Chem; 2013 Aug; 288(32):23447-56. PubMed ID: 23779105
[TBL] [Abstract][Full Text] [Related]
32. Structural Insights into Mycobacterium tuberculosis Rv2671 Protein as a Dihydrofolate Reductase Functional Analogue Contributing to para-Aminosalicylic Acid Resistance.
Cheng YS; Sacchettini JC
Biochemistry; 2016 Feb; 55(7):1107-19. PubMed ID: 26848874
[TBL] [Abstract][Full Text] [Related]
33. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
[TBL] [Abstract][Full Text] [Related]
34. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed
Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y
Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the embC-embA intergenic region contribute to Mycobacterium tuberculosis resistance to ethambutol.
Cui Z; Li Y; Cheng S; Yang H; Lu J; Hu Z; Ge B
Antimicrob Agents Chemother; 2014 Nov; 58(11):6837-43. PubMed ID: 25182646
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide DNA methylation and transcriptome and proteome changes in Mycobacterium tuberculosis with para-aminosalicylic acid resistance.
Li HC; Chen T; Yu L; Guo HX; Chen L; Chen YH; Chen M; Zhao J; Yan HM; Zhou L; Wang W
Chem Biol Drug Des; 2020 Jan; 95(1):104-112. PubMed ID: 31562690
[TBL] [Abstract][Full Text] [Related]
37. Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.
Torres JN; Paul LV; Rodwell TC; Victor TC; Amallraja AM; Elghraoui A; Goodmanson AP; Ramirez-Busby SM; Chawla A; Zadorozhny V; Streicher EM; Sirgel FA; Catanzaro D; Rodrigues C; Gler MT; Crudu V; Catanzaro A; Valafar F
Emerg Microbes Infect; 2015 Jul; 4(7):e42. PubMed ID: 26251830
[TBL] [Abstract][Full Text] [Related]
38. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.
Vilchèze C; Copeland J; Keiser TL; Weisbrod T; Washington J; Jain P; Malek A; Weinrick B; Jacobs WR
mBio; 2018 May; 9(3):. PubMed ID: 29844114
[TBL] [Abstract][Full Text] [Related]
39. Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of
Zhang T; Jiang G; Wen S; Huo F; Wang F; Huang H; Pang Y
Infect Drug Resist; 2019; 12():825-829. PubMed ID: 31114264
[No Abstract] [Full Text] [Related]
40. Knocking out salicylate biosynthesis genes in Mycobacterium smegmatis induces hypersensitivity to p-aminosalicylate (PAS).
Nagachar N; Ratledge C
FEMS Microbiol Lett; 2010 Oct; 311(2):193-9. PubMed ID: 20735479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
